We have identified a list of several trending stocks that appear have recently received buy ratings from top Wall Street analysts and are showing positive investor sentiment, as well as news headlines. With that said, our editors here at wallstreetmovers.com, are adding these tech companies to our watchlist to see if this momentum continues.
Summary: Avient Corporation provides specialized and sustainable material solutions. Avient Corporation, formerly known as PolyOne Corporation, is based in CLEVELAND.
- Recent AVNT Stock Price: $42.93
- AVNT Yearly Gain: -16.36%
- AVNT Market Cap: $3.90B
- AVNT P/E Ratio: 5.576
Will AVNT's stock price go up? Is there an accurate AVNT stock forecast available?
TipRanks.com reports that Avient currently has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $47.00. The target pricing ranges from a high AVNT forecast of $52.00 down to a low forecast of $40.00. Avient (AVNT)’s last closing stock price was $42.93 which would put the average price target at 9.48% upside.
In addition, TradingView issued a Strong Buy rating for AVNT over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on AVNT.
Other analysts covering AVNT include:
- Michael Sison of Wells Fargo issued a Buy rating with the price target of $ 46 on 4 days ago
- Kristen Owen of Oppenheimer issued a Buy rating with the price target of $ 50 on 4 days ago
- PJ Juvekar of Citigroup issued a Buy rating with the price target of $ 48 on 4 days ago
- Frank Mitsch of Fermium Research issued a Buy rating with the price target of $ 46 on 4 days ago
If you are wondering if AVNT is a good stock to buy, here are 3rd party ratings for AVNT:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 30% (175 out of 251)
What is the sentiment on the street regarding Avient? (Current ratings compiled by TipRanks.com)
- AVNT News Sentiment: Very Bullish
- AVNT Blogger Consensus: Bullish
- AVNT Media Buzz: Very High
- AVNT Insider Signal: ―
- AVNT Investor Sentiment: Very Positive
- AVNT Hedge Fund signal: Very Negative
The stock market is extremely volatile, and you need to do your own research on AVNT including scouring the social networks like AVNT StockTwits before you decide to make any investment.
Click here for AVNT chart >>
Summary: Lamb Weston Holdings, Inc. is a leading global manufacturer, marketer and distributor of value-added frozen potato products, particularly French fries, and also provides a range of appetizers. The company mainly serves retail and foodservices customers. Lamb Weston operates through the following segments: Global (this includes the top 100 North American restaurant chains and international customers such as global and regional restaurant chains, foodservice distributors, and retailers. Global, Foodservice and Retail.
- Recent LW Stock Price: $100.48
- LW Yearly Gain: 52.98%
- LW Market Cap: $14.46B
- LW P/E Ratio: 30.726
Will LW's stock price go up? Is there an accurate LW stock forecast available?
TipRanks.com reports that Lamb Weston Holdings currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $111.00. The target pricing ranges from a high LW forecast of $115.00 down to a low forecast of $107.00. Lamb Weston Holdings (LW)’s last closing stock price was $100.48 which would put the average price target at 10.47% upside.
In addition, TradingView issued a Buy rating for LW over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on LW.
Other analysts covering LW include:
- Thomas Palmer of J.P. Morgan issued a Buy rating with the price target of $ 112 on 1 month ago
- Peter Galbo of Bank of America Securities issued a Buy rating with the price target of $ 115 on 1 month ago
- Andrew Lazar of Barclays issued a Buy rating with the price target of $ 110 on 1 month ago
- Robert Dickerson of Jefferies issued a Buy rating with the price target of $ 99 on 4 months ago
If you are wondering if LW is a good stock to buy, here are 3rd party ratings for LW:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Strong Buy, Top 28% (71 out of 251)
What is the sentiment on the street regarding Lamb Weston Holdings? (Current ratings compiled by TipRanks.com)
- LW News Sentiment: Very Bullish
- LW Blogger Consensus: Bullish
- LW Media Buzz: Medium
- LW Insider Signal: Negative
- LW Investor Sentiment: Very Positive
- LW Hedge Fund signal: Very Positive
The stock market is extremely volatile, and you need to do your own research on LW including scouring the social networks like LW StockTwits before you decide to make any investment.
Click here for LW chart >>
Summary: Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.
- Recent HRMY Stock Price: $49.27
- HRMY Yearly Gain: 28.24%
- HRMY Market Cap: $2.92B
- HRMY P/E Ratio: 19.289
Will HRMY's stock price go up? Is there an accurate HRMY stock forecast available?
TipRanks.com reports that Harmony Biosciences Holdings currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $68.00. The target pricing ranges from a high HRMY forecast of $70.00 down to a low forecast of $62.00. Harmony Biosciences Holdings (HRMY)’s last closing stock price was $49.27 which would put the average price target at 38.02% upside.
In addition, TradingView issued a Neutral rating for HRMY over the next month, Barchart.com has a sell rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on HRMY.
Other analysts covering HRMY include:
- Chris Howerton of Jefferies issued a Buy rating with the price target of $ 62 on 1 week ago
- Ami Fadia of Needham issued a Buy rating with the price target of $ 70 on 3 weeks ago
- David Amsellem of Piper Sandler issued a Buy rating with the price target of $ 70 on 1 month ago
- Danielle Brill of Raymond James issued a Buy rating with the price target of $ 62 on 3 months ago
If you are wondering if HRMY is a good stock to buy, here are 3rd party ratings for HRMY:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 37% (93 out of 251)
What is the sentiment on the street regarding Harmony Biosciences Holdings? (Current ratings compiled by TipRanks.com)
- HRMY News Sentiment: Very Bullish
- HRMY Blogger Consensus: Bullish
- HRMY Media Buzz: Medium
- HRMY Insider Signal: Negative
- HRMY Investor Sentiment: Very Positive
- HRMY Hedge Fund signal: Neutral
The stock market is extremely volatile, and you need to do your own research on HRMY including scouring the social networks like HRMY StockTwits before you decide to make any investment.
Click here for HRMY chart >>
Summary: G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.
- Recent GTHX Stock Price: $4.02
- GTHX Yearly Gain: -58.04%
- GTHX Market Cap: $203.46M
- GTHX P/E Ratio: -1.114
Will GTHX's stock price go up? Is there an accurate GTHX stock forecast available?
TipRanks.com reports that G1 Therapeutics currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.80. The target pricing ranges from a high GTHX forecast of $19.00 down to a low forecast of $6.00. G1 Therapeutics (GTHX)’s last closing stock price was $4.02 which would put the average price target at 218.41% upside.
In addition, TradingView issued a n/a (possibly response change) rating for GTHX over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on GTHX.
Other analysts covering GTHX include:
- Thomas Shrader of BTIG issued a Buy rating with the price target of $ 6 on 1 week ago
- Edward White of H.C. Wainwright issued a Buy rating with the price target of $ 11 on 1 week ago
- Gil Blum of Needham issued a Buy rating with the price target of $ 18 on 1 week ago
- Anupam Rama of J.P. Morgan issued a Hold rating with the price target of $ 10 on 3 weeks ago
If you are wondering if GTHX is a good stock to buy, here are 3rd party ratings for GTHX:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 37% (93 out of 251)
What is the sentiment on the street regarding G1 Therapeutics? (Current ratings compiled by TipRanks.com)
- GTHX News Sentiment: Very Bullish
- GTHX Blogger Consensus: Bullish
- GTHX Media Buzz: Very High
- GTHX Insider Signal: Negative
- GTHX Investor Sentiment: Very Positive
- GTHX Hedge Fund signal: Positive
The stock market is extremely volatile, and you need to do your own research on GTHX including scouring the social networks like GTHX StockTwits before you decide to make any investment.
Click here for GTHX chart >>
Summary: Teck Resources Limited is a diversified resource company committed to mining and mineral development with business units focused on steelmaking coal, copper, zinc and energy. The company's principal products include steelmaking coal; copper concentrates and refined copper cathodes; refined zinc and zinc concentrates; energy products, such as bitumen; and lead concentrates. It also produces molybdenum, gold, silver, germanium, indium, mercury, and cadmium, as well as chemicals, industrial products, and fertilizers. The company also holds interest in oil sands projects. The company expertise includes a wide array of activities related to exploration, development, mining and minerals processing, including smelting and refining. It operates through the following segments -Steelmaking Coal, Copper, Zinc and Energy.
- Recent TECK Stock Price: $44.12
- TECK Yearly Gain: 26.78%
- TECK Market Cap: $22.57B
- TECK P/E Ratio: 6.599
Will TECK's stock price go up? Is there an accurate TECK stock forecast available?
TipRanks.com reports that Teck Resources currently has 17 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $45.38. The target pricing ranges from a high TECK forecast of $55.66 down to a low forecast of $33.40. Teck Resources (TECK)’s last closing stock price was $44.12 which would put the average price target at 2.86% upside.
In addition, TradingView issued a Buy rating for TECK over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on TECK.
Other analysts covering TECK include:
- Orest Wowkodaw of Scotiabank issued a Buy rating with the price target of $ 47.5 on 3 days ago
- Chris LaFemina of Jefferies issued a Buy rating with the price target of $ 55.66 on 3 days ago
- Dalton Baretto of Canaccord Genuity issued a Buy rating with the price target of $ 51.95 on 4 days ago
- Sam Crittenden of RBC Capital issued a Buy rating with the price target of $ 47.5 on 4 days ago
If you are wondering if TECK is a good stock to buy, here are 3rd party ratings for TECK:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Top 33% (84 out of 251)
What is the sentiment on the street regarding Teck Resources? (Current ratings compiled by TipRanks.com)
- TECK News Sentiment: Very Bullish
- TECK Blogger Consensus: Bullish
- TECK Media Buzz: Very High
- TECK Insider Signal: Negative
- TECK Investor Sentiment: Very Positive
- TECK Hedge Fund signal: Positive
The stock market is extremely volatile, and you need to do your own research on TECK including scouring the social networks like TECK StockTwits before you decide to make any investment.
Click here for TECK chart >>
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
The Editor, wallstreetmovers.com
WallStreetMovers.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to WallStreetMovers.com.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================